Literature DB >> 33884336

Combined bridging and antegrade stent placement during transmural treatment for malignant hilar biliary obstruction in a patient with surgically altered anatomy.

Hassan Atalla1,2, Hideyuki Shiomi1, Arata Sakai1, Atsuhiro Masuda1, Yuzo Kodama1.   

Abstract

Entities:  

Keywords:  CBD, common bile duct; E-ERCP, enteroscopy-assisted ERCP; EUS-HGS, EUS-guided hepaticogastrostomy; LHD, left hepatic duct; MHBO, malignant hilar biliary obstruction; RHD, right hepatic duct; SAA, surgically altered anatomy; SEMS, self-expandable metal stent; UDLC, uneven double-lumen cannula

Year:  2020        PMID： 33884336      PMCID： PMC7859656          DOI： 10.1016/j.vgie.2020.09.011

Source DB:  PubMed          Journal:  VideoGIE        ISSN： 2468-4481


× No keyword cloud information.
  4 in total

1.  Novel approach for successful endoscopic ultrasound-guided hepaticogastrostomy using a double-guidewire technique.

Authors:  Hideyuki Shiomi; Atsuhiro Masuda; Yuzo Kodama
Journal:  Dig Endosc       Date:  2019-01-27       Impact factor: 7.559

2.  Endoscopic ultrasound-guided biliary drainage for right hepatic bile duct obstruction: novel technical tips.

Authors:  Takeshi Ogura; Tatsushi Sano; Saori Onda; Akira Imoto; Daisuke Masuda; Kazuhiro Yamamoto; Masayuki Kitano; Toshihisa Takeuchi; Takuya Inoue; Kazuhide Higuchi
Journal:  Endoscopy       Date:  2014-09-29       Impact factor: 10.093

Review 3.  Technical tips for endoscopic ultrasound-guided hepaticogastrostomy.

Authors:  Takeshi Ogura; Kazuhide Higuchi
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

4.  Bilateral versus unilateral placement of metal stents for inoperable high-grade malignant hilar biliary strictures: a multicenter, prospective, randomized study (with video).

Authors:  Tae Hoon Lee; Tae Hyeon Kim; Jong Ho Moon; Sang Hyub Lee; Hyun Jong Choi; Young Hwangbo; Jong Jin Hyun; Jun-Ho Choi; Seok Jeong; Jong Hyeok Kim; Do Hyun Park; Joung-Ho Han; Sang-Heum Park
Journal:  Gastrointest Endosc       Date:  2017-05-04       Impact factor: 9.427
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.